Publications
Publications from OUS - The Lipid Clinic
434 publications found
Publications 2022
-
Do we need new lipid-lowering agents in the era of PCSK9 inhibitors? Recent advances
Kardiol Pol (in press)
DOI 10.33963/KP.a2022.0117, PubMed 35521719 -
Simple Nutrient-Based Rules vs. a Nutritionally Rich Plant-Centered Diet in Prediction of Future Coronary Heart Disease and Stroke: Prospective Observational Study in the US
Nutrients, 14 (3)
DOI 10.3390/nu14030469, PubMed 35276828 -
Postprandial Effects of Salmon Fishmeal and Whey on Metabolic Markers in Serum and Gene Expression in Liver Cells
Nutrients, 14 (8)
DOI 10.3390/nu14081593, PubMed 35458155 -
Resmetirom (MGL-3196) in Patients With Heterozygous Familial Hypercholesterolemia
J Am Coll Cardiol, 79 (12), 1220-1222
DOI 10.1016/j.jacc.2022.01.023, PubMed 35331419 -
Salmon fish protein supplement increases serum vitamin B12 and selenium concentrations: secondary analysis of a randomised controlled trial
Eur J Nutr (in press)
DOI 10.1007/s00394-022-02857-4, PubMed 35362766 -
Comprehensive lipid and metabolite profiling in healthy adults with low and high consumption of fatty fish: a cross-sectional study - CORRIGENDUM
Br J Nutr, 1-2 (in press)
DOI 10.1017/S0007114522001519, PubMed 35579033 -
What characterizes event-free elderly FH patients? A comprehensive lipoprotein profiling
Nutr Metab Cardiovasc Dis, 32 (7), 1651-1660
DOI 10.1016/j.numecd.2022.03.028, PubMed 35527125 -
Increased risk of peripheral artery disease in persons with familial hypercholesterolaemia: a prospective registry study
Eur J Prev Cardiol, 28 (18), e11-e13
DOI 10.1093/eurjpc/zwaa024, PubMed 33623989 -
Association of Familial Hypercholesterolemia and Statin Use With Risk of Dementia in Norway
JAMA Netw Open, 5 (4), e227715
DOI 10.1001/jamanetworkopen.2022.7715, PubMed 35438756 -
Statins seldom cause adverse reactions
Tidsskr Nor Laegeforen, 142 (2)
DOI 10.4045/tidsskr.21.0885, PubMed 35107944 -
Why we can probably trust public policy dietary guidelines for prevention
Eur J Prev Cardiol, 29 (6), e209-e210
DOI 10.1093/eurjpc/zwaa008, PubMed 33624034 -
A Three-Day Intervention With Granola Containing Cereal Beta-Glucan Improves Glycemic Response and Changes the Gut Microbiota in Healthy Individuals: A Crossover Study
Front Nutr, 9, 796362
DOI 10.3389/fnut.2022.796362, PubMed 35578615 -
Effects of dietary and exercise treatments on HDL subclasses in lactating women with overweight and obesity: a secondary analysis of a randomised controlled trial
Br J Nutr, 1-10 (in press)
DOI 10.1017/S0007114522000241, PubMed 35067237 -
Circulating Lipoproteins in Subjects with Morbid Obesity Undergoing Bariatric Surgery with Gastric Bypass or Sleeve Gastrectomy
Nutrients, 14 (12)
DOI 10.3390/nu14122381, PubMed 35745111
Publications 2021
-
Risk of Recurrent Coronary Events in Patients With Familial Hypercholesterolemia; A 10-Years Prospective Study
Front Pharmacol, 11, 560958
DOI 10.3389/fphar.2020.560958, PubMed 33737874 -
The Long-term Effect of Different Exercise Intensities on High-Density Lipoprotein Cholesterol in Older Men and Women Using the Per Protocol Approach: The Generation 100 Study
Mayo Clin Proc Innov Qual Outcomes, 5 (5), 859-871
DOI 10.1016/j.mayocpiqo.2021.07.002, PubMed 34585083 -
Children with familial hypercholesterolemia display changes in LDL and HDL function: A cross-sectional study
J Intern Med, 290 (5), 1083-1097
DOI 10.1111/joim.13383, PubMed 34506681 -
Long term follow-up of children with familial hypercholesterolemia and relatively normal LDL-cholesterol at diagnosis
J Clin Lipidol, 15 (2), 375-378
DOI 10.1016/j.jacl.2021.01.007, PubMed 33608220 -
Loss of statin treatment years during pregnancy and breastfeeding periods in women with familial hypercholesterolemia
Atherosclerosis, 335, 8-15
DOI 10.1016/j.atherosclerosis.2021.09.003, PubMed 34520888 -
Treatment goals in familial hypercholesterolemia - time to consider LDL-cholesterol burden
Eur J Prev Cardiol (in press)
DOI 10.1093/eurjpc/zwab228, PubMed 34935933 -
Thirty percent of children and young adults with familial hypercholesterolemia treated with statins have adherence issues
Am J Prev Cardiol, 6, 100180
DOI 10.1016/j.ajpc.2021.100180, PubMed 34327501 -
Left Ventricular Dysfunction in Arrhythmogenic Cardiomyopathy: Association With Exercise Exposure, Genetic Basis, and Prognosis
J Am Heart Assoc, 10 (8), e018680
DOI 10.1161/JAHA.120.018680, PubMed 33821670 -
Excess Aortic Pathology Risk in Patients with Genetically Verified Familial Hypercholesterolaemia: A Prospective Norwegian Registry Study
Eur J Vasc Endovasc Surg, 61 (4), 712-713
DOI 10.1016/j.ejvs.2020.12.019, PubMed 33485759 -
Comparison of methods to identify individuals with obesity at increased risk of functional impairment among a population of home-dwelling older adults
Br J Nutr, 1-8 (in press)
DOI 10.1017/S0007114521004128, PubMed 34749837 -
Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation - results from the GARFIELD-AF registry
Ann Med, 53 (1), 485-494
DOI 10.1080/07853890.2021.1893897, PubMed 33818226 -
What about reactions after COVID-19 infection or vaccination?
Tidsskr Nor Laegeforen, 141
DOI 10.4045/tidsskr.21.0582, PubMed 34505487 -
Retterstøl and colleagues respond
Tidsskr Nor Laegeforen, 141 (4)
DOI 10.4045/tidsskr.21.0122, PubMed 33685109 -
Lower treatment goals for LDL cholesterol should be introduced
Tidsskr Nor Laegeforen, 141 (2)
DOI 10.4045/tidsskr.20.0761, PubMed 33528123 -
Correction: Lower treatment goals for LDL cholesterol should be introduced
Tidsskr Nor Laegeforen, 141 (4)
DOI 10.4045/tidsskr.21.0096, PubMed 33685112 -
Dietary intake and lipid levels in Norwegian and Spanish children with familial hypercholesterolemia
Nutr Metab Cardiovasc Dis, 31 (4), 1299-1307
DOI 10.1016/j.numecd.2020.12.002, PubMed 33549456 -
LongITools: Dynamic longitudinal exposome trajectories in cardiovascular and metabolic noncommunicable diseases
Environ Epidemiol, 6 (1), e184
DOI 10.1097/EE9.0000000000000184, PubMed 35169663 -
Sulfur amino acid restriction, energy metabolism and obesity: a study protocol of an 8-week randomized controlled dietary intervention with whole foods and amino acid supplements
J Transl Med, 19 (1), 153
DOI 10.1186/s12967-021-02824-3, PubMed 33858441 -
Gender differences in nutrition literacy levels among university students and employees: a descriptive study
J Nutr Sci, 10, e56
DOI 10.1017/jns.2021.47, PubMed 34367630 -
The homeoviscous adaptation to dietary lipids (HADL) model explains controversies over saturated fat, cholesterol, and cardiovascular disease risk
Am J Clin Nutr, 113 (2), 277-289
DOI 10.1093/ajcn/nqaa322, PubMed 33471045 -
Novel associations between parental and newborn cord blood metabolic profiles in the Norwegian Mother, Father and Child Cohort Study
BMC Med, 19 (1), 91
DOI 10.1186/s12916-021-01959-w, PubMed 33849542 -
Cholesterol at ages 6, 12 and 24 months: Tracking and associations with diet and maternal cholesterol in the Infant Cholesterol Study
Atherosclerosis, 326, 11-16
DOI 10.1016/j.atherosclerosis.2021.04.017, PubMed 33990045
Publications 2020
-
Prevalence of genetically verified familial hypercholesterolemia among young (<45 years) Norwegian patients hospitalized with acute myocardial infarction
J Clin Lipidol, 14 (3), 339-345
DOI 10.1016/j.jacl.2020.04.002, PubMed 32418822 -
Corrigendum to "Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia" J Clin Lipidol 11 (2017) 1338-1346
J Clin Lipidol, 14 (5), 742
DOI 10.1016/j.jacl.2020.09.010, PubMed 33138962 -
Beneficial effect on serum cholesterol levels, but not glycaemic regulation, after replacing SFA with PUFA for 3 d: a randomised crossover trial
Br J Nutr, 125 (8), 915-925
DOI 10.1017/S0007114520003402, PubMed 32873354 -
Subjects with familial hypercholesterolemia have lower aortic valve area and higher levels of inflammatory biomarkers
J Clin Lipidol, 15 (1), 134-141
DOI 10.1016/j.jacl.2020.12.006, PubMed 33358307 -
Anti-inflammatory effects of non-statin low-density lipoprotein cholesterol-lowering drugs: an unused potential?
Scand Cardiovasc J, 54 (5), 274-279
DOI 10.1080/14017431.2020.1775878, PubMed 32500743 -
Lipoprotein retention in the vascular wall - a potential therapeutic target?
Tidsskr. Nor. Laegeforen., 140 (10), 987-989 -
Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study
Cardiovasc Drugs Ther, 34 (4), 515-523
DOI 10.1007/s10557-020-06984-0, PubMed 32363493 -
Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME®
Diab Vasc Dis Res, 17 (6), 1479164120975256
DOI 10.1177/1479164120975256, PubMed 33307785 -
Nutritional challenges in children and adolescents with Down syndrome
Lancet Child Adolesc Health, 4 (6), 455-464
DOI 10.1016/S2352-4642(19)30400-6, PubMed 32450124 -
Lecithin:cholesterol acyltransferase: symposium on 50 years of biomedical research from its discovery to latest findings
J Lipid Res, 61 (8), 1142-1149
DOI 10.1194/jlr.S120000720, PubMed 32482717 -
Effects of dietary methionine and cysteine restriction on plasma biomarkers, serum fibroblast growth factor 21, and adipose tissue gene expression in women with overweight or obesity: a double-blind randomized controlled pilot study
J Transl Med, 18 (1), 122
DOI 10.1186/s12967-020-02288-x, PubMed 32160926 -
Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action
JAMA Cardiol, 5 (2), 217-229
DOI 10.1001/jamacardio.2019.5173, PubMed 31895433 -
Factors influencing the opportunities of supporting staff to promote a healthy diet in adults with intellectual disabilities
J Appl Res Intellect Disabil, 34 (3), 733-741
DOI 10.1111/jar.12846, PubMed 33274594 -
Familial hypercholesterolaemia: history, diagnosis, screening, management and challenges
Heart, 106 (24), 1940-1946
DOI 10.1136/heartjnl-2019-316276, PubMed 32933999 -
Evaluating the use of the heart age tool in community pharmacies: a 4-week cluster-randomized controlled trial
Eur J Public Health, 30 (6), 1139-1145
DOI 10.1093/eurpub/ckaa048, PubMed 32206810 -
2.5-fold increased risk of recurrent acute myocardial infarction with familial hypercholesterolemia
Atherosclerosis, 319, 28-34
DOI 10.1016/j.atherosclerosis.2020.12.019, PubMed 33465659 -
Genetic testing is essential for initiating statin therapy in children with familial hypercholesterolemia: Examples from Scandinavia
Atherosclerosis, 316, 48-52
DOI 10.1016/j.atherosclerosis.2020.11.027, PubMed 33302044 -
Fatty acid profile and estimated desaturase activities in whole blood are associated with metabolic health
Lipids Health Dis, 19 (1), 102
DOI 10.1186/s12944-020-01282-y, PubMed 32438926 -
A comprehensive metabolic profiling of the metabolically healthy obesity phenotype
Lipids Health Dis, 19 (1), 90
DOI 10.1186/s12944-020-01273-z, PubMed 32386512
Publications 2019
-
Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia
Adv Ther, 36 (7), 1786-1811
DOI 10.1007/s12325-019-00985-8, PubMed 31102204 -
LDL-cholesterol goal achievement, cardiovascular disease, and attributed risk of Lp(a) in a large cohort of predominantly genetically verified familial hypercholesterolemia
J Clin Lipidol, 13 (2), 279-286
DOI 10.1016/j.jacl.2019.01.010, PubMed 30910667 -
Serum Omega-6 Fatty Acids and Immunology-Related Gene Expression in Peripheral Blood Mononuclear Cells: A Cross-Sectional Analysis in Healthy Children
Mol Nutr Food Res, 63 (7), e1800990
DOI 10.1002/mnfr.201800990, PubMed 30702198 -
Long-Term Efficacy and Safety of Evolocumab in Patients With Hypercholesterolemia
J Am Coll Cardiol, 74 (17), 2132-2146
DOI 10.1016/j.jacc.2019.08.1024, PubMed 31648705 -
Lower risk of smoking-related cancer in individuals with familial hypercholesterolemia compared with controls: a prospective matched cohort study
Sci Rep, 9 (1), 19273
DOI 10.1038/s41598-019-55682-x, PubMed 31848411 -
Impaired HDL Function Amplifies Systemic Inflammation in Common Variable Immunodeficiency
Sci Rep, 9 (1), 9427
DOI 10.1038/s41598-019-45861-1, PubMed 31263122 -
Association of Low-Density Lipoprotein Cholesterol With Risk of Aortic Valve Stenosis in Familial Hypercholesterolemia
JAMA Cardiol, 4 (11), 1156-1159
DOI 10.1001/jamacardio.2019.3903, PubMed 31617858 -
Efficacy and Safety of Alirocumab 300 mg Every 4 Weeks in Individuals With Type 2 Diabetes on Maximally Tolerated Statin
J Clin Endocrinol Metab, 104 (11), 5253-5262
DOI 10.1210/jc.2018-02703, PubMed 31166599 -
Lipoprotein(a) concentration is associated with plasma arachidonic acid in subjects with familial hypercholesterolaemia
Br J Nutr, 122 (7), 790-799
DOI 10.1017/S0007114519001600, PubMed 31262370 -
Profiling of immune-related gene expression in children with familial hypercholesterolaemia
J Intern Med, 287 (3), 310-321
DOI 10.1111/joim.13001, PubMed 31631426 -
Community pharmacies offer a potential high-yield and convenient arena for total cholesterol and CVD risk screening
Eur J Public Health, 29 (1), 17-23
DOI 10.1093/eurpub/cky190, PubMed 30239673 -
Milk and Dairy Product Consumption and Inflammatory Biomarkers: An Updated Systematic Review of Randomized Clinical Trials
Adv Nutr, 10 (suppl_2), S239-S250
DOI 10.1093/advances/nmy072, PubMed 31089732 -
Economic evaluation of lipid lowering with PCSK9 inhibitors in patients with familial hypercholesterolemia: Methodological aspects
Atherosclerosis, 287, 140-146
DOI 10.1016/j.atherosclerosis.2019.06.900, PubMed 31280039 -
Infant cholesterol and glycated haemoglobin concentrations vary widely-Associations with breastfeeding, infant diet and maternal biomarkers
Acta Paediatr, 109 (1), 115-121
DOI 10.1111/apa.14936, PubMed 31299108 -
Postprandial changes in gene expression of cholesterol influx and efflux mediators after intake of SFA compared with n-6 PUFA in subjects with and without familial hypercholesterolaemia: secondary outcomes of a randomised controlled trial
J Nutr Sci, 8, e27
DOI 10.1017/jns.2019.25, PubMed 31448116
Publications 2018
-
Individualized low-density lipoprotein cholesterol reduction with alirocumab titration strategy in heterozygous familial hypercholesterolemia: Results from an open-label extension of the ODYSSEY LONG TERM trial
J Clin Lipidol, 13 (1), 138-147
DOI 10.1016/j.jacl.2018.11.007, PubMed 30591415 -
Long-term safety and efficacy of alirocumab in patients with heterozygous familial hypercholesterolemia: An open-label extension of the ODYSSEY program
Atherosclerosis, 278, 307-314
DOI 10.1016/j.atherosclerosis.2018.08.036, PubMed 30293878 -
Efficacy, safety, and tolerability of evolocumab in pediatric patients with heterozygous familial hypercholesterolemia: Rationale and design of the HAUSER-RCT study
J Clin Lipidol, 12 (5), 1199-1207
DOI 10.1016/j.jacl.2018.05.007, PubMed 30318065 -
Sex differences in cholesterol levels from birth to 19 years of age may lead to increased cholesterol burden in females with FH
J Clin Lipidol, 12 (3), 748-755.e2
DOI 10.1016/j.jacl.2018.02.021, PubMed 29609857 -
The right to a health promoting diet for people with intellectual disabilities
Tidsskr. Nor. Laegeforen., 138 (2), 122-123 -
Alirocumab dosing patterns during 40 months of open-label treatment in patients with heterozygous familial hypercholesterolemia
J Clin Lipidol, 12 (6), 1463-1470
DOI 10.1016/j.jacl.2018.08.011, PubMed 30287210 -
Risk of Ischemic Stroke and Total Cerebrovascular Disease in Familial Hypercholesterolemia
Stroke, 50 (1), 172-174
DOI 10.1161/STROKEAHA.118.023456, PubMed 30580708 -
Securing rights and nutritional health for persons with intellectual disabilities - a pressing challenge
Food Nutr Res, 62
DOI 10.29219/fnr.v62.1268, PubMed 29899685 -
Are PCSK9 Inhibitors Cost Effective?
Pharmacoeconomics, 36 (9), 1031-1041
DOI 10.1007/s40273-018-0671-0, PubMed 29777433 -
Response by Kusters et al to Letter Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)"
Circulation, 137 (6), 641-642
DOI 10.1161/CIRCULATIONAHA.117.031676, PubMed 29431667 -
Some children with a familial hypercholesterolemia mutation may exhibit persistent low LDL levels
J Clin Lipidol, 12 (5), 1327-1328
DOI 10.1016/j.jacl.2018.06.012, PubMed 30033003 -
Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials)
Am J Cardiol, 121 (8), 940-948
DOI 10.1016/j.amjcard.2017.12.040, PubMed 29472008 -
Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia
Heart, 104 (19), 1600-1607
DOI 10.1136/heartjnl-2017-312706, PubMed 29622598 -
The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions
Heart Fail Rev, 23 (3), 303-323
DOI 10.1007/s10741-018-9685-0, PubMed 29516230 -
Response to the editor
Heart Fail Rev (in press)
DOI 10.1007/s10741-018-9723-y, PubMed 29968222 -
Author's response to: letter to the editor
Heart Fail Rev, 23 (5), 819
DOI 10.1007/s10741-018-9728-6, PubMed 30043131 -
Effect of low carbohydrate high fat diet on LDL cholesterol and gene expression in normal-weight, young adults: A randomized controlled study
Atherosclerosis, 279, 52-61
DOI 10.1016/j.atherosclerosis.2018.10.013, PubMed 30408717 -
Evaluation of a short Food Frequency Questionnaire to assess cardiovascular disease-related diet and lifestyle factors
Food Nutr Res, 62
DOI 10.29219/fnr.v62.1370, PubMed 29720928 -
A randomized controlled trial in Norwegian pharmacies on effects of risk alert and advice in people with elevated cardiovascular risk
Prev Med Rep, 12, 79-86
DOI 10.1016/j.pmedr.2018.08.004, PubMed 30191097 -
Familial hypercholesterolemia and young patients' thoughts on own condition and treatment
Patient Educ Couns, 102 (5), 1005-1012
DOI 10.1016/j.pec.2018.12.025, PubMed 30606641
Publications 2017
-
Recommended Nordic diet and risk markers for cardiovascular disease
Tidsskr Nor Laegeforen, 137 (10), 721-726
DOI 10.4045/tidsskr.16.0243, PubMed 28551971 -
A physically fit woman in her thirties with exertional dyspnoea
Tidsskr Nor Laegeforen, 137 (6), 456-458
DOI 10.4045/tidsskr.16.0538, PubMed 28332800 -
Treatment goal attainment in children with familial hypercholesterolemia: A cohort study of 302 children in Norway
J Clin Lipidol, 12 (2), 375-382
DOI 10.1016/j.jacl.2017.11.009, PubMed 29310990 -
Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)
Circulation, 136 (4), 359-366
DOI 10.1161/CIRCULATIONAHA.116.025158, PubMed 28592434 -
Comprehensive lipid and metabolite profiling of children with and without familial hypercholesterolemia: A cross-sectional study
Atherosclerosis, 266, 48-57
DOI 10.1016/j.atherosclerosis.2017.09.021, PubMed 28963918 -
Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia
J Clin Lipidol, 11 (6), 1338-1346.e7
DOI 10.1016/j.jacl.2017.08.016, PubMed 28964736 -
Gene expression is differentially regulated in skeletal muscle and circulating immune cells in response to an acute bout of high-load strength exercise
Genes Nutr, 12, 8
DOI 10.1186/s12263-017-0556-4, PubMed 28270867 -
Consumption of protein-enriched milk has minor effects on inflammation in older adults-A 12-week double-blind randomized controlled trial
Mech Ageing Dev, 162, 1-8
DOI 10.1016/j.mad.2017.01.011, PubMed 28163108 -
Alirocumab efficacy in patients with double heterozygous, compound heterozygous, or homozygous familial hypercholesterolemia
J Clin Lipidol, 12 (2), 390-396.e8
DOI 10.1016/j.jacl.2017.12.008, PubMed 29396260 -
Increased risk of heart failure and atrial fibrillation in heterozygous familial hypercholesterolemia
Atherosclerosis, 266, 69-73
DOI 10.1016/j.atherosclerosis.2017.09.027, PubMed 28992466 -
Bariatric surgery reduces fasting total fatty acids and increases n-3 polyunsaturated fatty acids in morbidly obese individuals
Scand J Clin Lab Invest, 77 (8), 628-633
DOI 10.1080/00365513.2017.1393691, PubMed 29069988 -
Long-term Low-Density Lipoprotein Cholesterol-Lowering Efficacy, Persistence, and Safety of Evolocumab in Treatment of Hypercholesterolemia: Results Up to 4 Years From the Open-Label OSLER-1 Extension Study
JAMA Cardiol, 2 (6), 598-607
DOI 10.1001/jamacardio.2017.0747, PubMed 28291870 -
Mortalitet og kardiovaskulær morbiditet ved familiær hyperkolesterolemi
Tidsskr Nor Laegeforen, 137 (3), 225
DOI 10.4045/tidsskr.16.1015, PubMed 28181769 -
Misleading about diet in new national guideline for prevention of cardiovascular disease
Tidsskr. Nor. Laegeforen., 137 (20), 1584-1586 -
[Misleading about diet in a new national guideline for the prevention of cardiovascular disease]
Tidsskr Nor Laegeforen, 137 (20)
DOI 10.4045/tidsskr.17.0834, PubMed 29094560 -
More harm than benefit - how much should the patients know?
Tidsskr. Nor. Laegeforen., 137 (9), 598 -
Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics
Lipids Health Dis, 16 (1), 115
DOI 10.1186/s12944-017-0511-9, PubMed 28606150 -
Saturated fat -a never ending story?
Food Nutr Res, 61 (1), 1377572
DOI 10.1080/16546628.2017.1377572, PubMed 29056889 -
Does dietary fat affect inflammatory markers in overweight and obese individuals?-a review of randomized controlled trials from 2010 to 2016
Genes Nutr, 12, 26
DOI 10.1186/s12263-017-0580-4, PubMed 29043006
Publications 2016
-
Comments on Moderate Alcohol Consumption and Mortality
J Stud Alcohol Drugs, 77 (5), 834-6
DOI 10.15288/jsad.2016.77.834, PubMed 27588543 -
Data on circulating leukocyte subpopulations and inflammatory proteins in children with familial hypercholesterolemia and healthy children
Data Brief, 10, 587-592
DOI 10.1016/j.dib.2016.12.042, PubMed 28070551 -
Altered leukocyte distribution under hypercholesterolemia: A cross-sectional study in children with familial hypercholesterolemia
Atherosclerosis, 256, 67-74
DOI 10.1016/j.atherosclerosis.2016.11.031, PubMed 28024183 -
LDL cholesterol in early pregnancy and offspring cardiovascular disease risk factors
J Clin Lipidol, 10 (6), 1369-1378.e7
DOI 10.1016/j.jacl.2016.08.016, PubMed 27919354 -
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration
Atheroscler Suppl, 22, 1-32
DOI 10.1016/j.atherosclerosissup.2016.10.001, PubMed 27939304 -
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro
Diabetologia, 59 (10), 2134-44
DOI 10.1007/s00125-016-4036-y, PubMed 27421726 -
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 monoclonal antibody alirocumab vs placebo in patients with heterozygous familial hypercholesterolemia
J Clin Lipidol, 11 (1), 195-203.e4
DOI 10.1016/j.jacl.2016.12.004, PubMed 28391886 -
Replacing statins with PCSK9-inhibitors and delaying treatment until 18 years of age in patients with familial hypercholesterolaemia is not a good idea
Eur Heart J, 37 (17), 1357-9
DOI 10.1093/eurheartj/ehw098, PubMed 27026748 -
A 3-year study of atorvastatin in children and adolescents with heterozygous familial hypercholesterolemia
J Clin Lipidol, 10 (5), 1153-1162.e3
DOI 10.1016/j.jacl.2016.05.010, PubMed 27678432 -
Simultaneous Reduction in Both HbA1c and Body Weight with Canagliflozin Versus Glimepiride in Patients with Type 2 Diabetes on Metformin
Diabetes Ther, 7 (2), 269-78
DOI 10.1007/s13300-016-0163-1, PubMed 26984361 -
Health-related quality of life, sense of coherence and leisure-time physical activity in women after an acute myocardial infarction
J Clin Nurs, 26 (7-8), 975-982
DOI 10.1111/jocn.13411, PubMed 27239746 -
Effects of low-carbohydrate diets v. low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of randomised controlled trials
Br J Nutr, 115 (3), 466-79
DOI 10.1017/S0007114515004699, PubMed 26768850 -
Low-carbohydrate diets increase LDL-cholesterol, and thereby indicate increased risk of CVD
Br J Nutr, 115 (12), 2264-6
DOI 10.1017/S0007114516001343, PubMed 27376624 -
Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013
Eur J Prev Cardiol, 24 (2), 137-144
DOI 10.1177/2047487316676135, PubMed 27794106 -
A systematic review of current studies in patients with familial hypercholesterolemia by use of national familial hypercholesterolemia registries
Curr Opin Lipidol, 27 (4), 388-97
DOI 10.1097/MOL.0000000000000300, PubMed 27070076 -
Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study
Eur J Prev Cardiol, 23 (18), 1962-1969
DOI 10.1177/2047487316666371, PubMed 27558979 -
The prevalence of metabolic risk factors of atherosclerotic cardiovascular disease in Williams syndrome, Prader-Willi syndrome, and Down syndrome
J. Intellect. Dev. Dis., 41 (3), 187-196
DOI 10.3109/13668250.2016.1167845 -
Bioavailability of n-3 fatty acids from n-3-enriched foods and fish oil with different oxidative quality in healthy human subjects: a randomised single-meal cross-over study
J Nutr Sci, 5, e43
DOI 10.1017/jns.2016.34, PubMed 28620470 -
Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia
J Clin Lipidol, 10 (4), 816-823
DOI 10.1016/j.jacl.2016.02.015, PubMed 27578112 -
A phase III randomized trial evaluating alirocumab 300 mg every 4 weeks as monotherapy or add-on to statin: ODYSSEY CHOICE I
Atherosclerosis, 254, 254-262
DOI 10.1016/j.atherosclerosis.2016.08.043, PubMed 27639753 -
Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemia
Atherosclerosis, 252, 21-27
DOI 10.1016/j.atherosclerosis.2016.07.913, PubMed 27494447
Publications 2015
-
Efficacy and Safety of Pitavastatin in Children and Adolescents at High Future Cardiovascular Risk
J Pediatr, 167 (2), 338-43.e5
DOI 10.1016/j.jpeds.2015.05.006, PubMed 26059337 -
Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study
J Clin Lipidol, 9 (6), 741-750
DOI 10.1016/j.jacl.2015.07.011, PubMed 26687694 -
Effects of Exercise on Gene Expression of Inflammatory Markers in Human Peripheral Blood Cells: A Systematic Review
Curr Cardiovasc Risk Rep, 9 (7), 34
DOI 10.1007/s12170-015-0463-4, PubMed 26005511 -
Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study
Lancet, 385 (9983), 2153-61
DOI 10.1016/S0140-6736(14)62115-2, PubMed 25743173 -
ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia
Eur Heart J, 36 (43), 2996-3003
DOI 10.1093/eurheartj/ehv370, PubMed 26330422 -
Vascular risk factors, vascular disease, lipids and lipid targets in patients with familial dysbetalipoproteinemia: a European cross-sectional study
Atherosclerosis, 240 (1), 90-7
DOI 10.1016/j.atherosclerosis.2015.02.046, PubMed 25768710 -
Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death
Eur Heart J, 37 (17), 1398-405
DOI 10.1093/eurheartj/ehv602, PubMed 26586781 -
Long-term follow-up of young adults with familial hypercholesterolemia after participation in clinical trials during childhood
J Clin Lipidol, 9 (6), 778-785
DOI 10.1016/j.jacl.2015.08.008, PubMed 26687698 -
Evolocumab (AMG 145) for primary hypercholesterolemia
Expert Rev Cardiovasc Ther, 13 (5), 477-88
DOI 10.1586/14779072.2015.1030395, PubMed 25824308 -
[Increased mortality in familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 135 (11), 1024-5
DOI 10.4045/tidsskr.15.0244, PubMed 26080775 -
Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia
Atherosclerosis, 243 (1), 155-60
DOI 10.1016/j.atherosclerosis.2015.09.014, PubMed 26386212 -
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events
N Engl J Med, 372 (16), 1489-99
DOI 10.1056/NEJMoa1501031, PubMed 25773378 -
Efficacy and tolerability of saxagliptin compared with glimepiride in elderly patients with type 2 diabetes: a randomized, controlled study (GENERATION)
Diabetes Obes Metab, 17 (7), 630-8
DOI 10.1111/dom.12461, PubMed 25761977 -
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
Eur Heart J, 36 (36), 2425-37
DOI 10.1093/eurheartj/ehv157, PubMed 26009596
Publications 2014
-
Type 1 hyperlipoproteinemia due to a novel deletion of exons 3 and 4 in the GPIHBP1 gene
Atherosclerosis, 234 (1), 30-3
DOI 10.1016/j.atherosclerosis.2014.02.005, PubMed 24589565 -
Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment
Atherosclerosis, 233 (2), 561-567
DOI 10.1016/j.atherosclerosis.2014.01.022, PubMed 24530965 -
Efficacy and safety of alirocumab in patients with heterozygous familial hypercholesterolemia not adequately controlled with current lipid-lowering therapy: design and rationale of the ODYSSEY FH studies
Cardiovasc Drugs Ther, 28 (3), 281-9
DOI 10.1007/s10557-014-6523-z, PubMed 24842558 -
Canagliflozin provides durable glycemic improvements and body weight reduction over 104 weeks versus glimepiride in patients with type 2 diabetes on metformin: a randomized, double-blind, phase 3 study
Diabetes Care, 38 (3), 355-64
DOI 10.2337/dc13-2762, PubMed 25205142 -
Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010
J Am Heart Assoc, 3 (6), e001236
DOI 10.1161/JAHA.114.001236, PubMed 25468658 -
Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review
Atherosclerosis, 235 (2), 299-309
DOI 10.1016/j.atherosclerosis.2014.05.917, PubMed 24908240 -
Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials
J Am Coll Cardiol, 63 (13), 1278-1288
DOI 10.1016/j.jacc.2014.01.006, PubMed 24509273 -
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
Lancet, 385 (9965), 331-40
DOI 10.1016/S0140-6736(14)61399-4, PubMed 25282519 -
Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study
Lancet Diabetes Endocrinol, 2 (6), 455-63
DOI 10.1016/S2213-8587(14)70006-3, PubMed 24731671 -
Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach
Eur J Hum Genet, 23 (3), 381-7
DOI 10.1038/ejhg.2014.101, PubMed 24916650
Publications 2013
-
[Lipid profile of healthy persons with low-carbohydrate diet]
Tidsskr Nor Laegeforen, 133 (11), 1193-6
DOI 10.4045/tidsskr.12.0034, PubMed 23759780 -
[M. Baumann and colleagues replies]
Tidsskr Nor Laegeforen, 133 (16), 1685-6
DOI 10.4045/tidsskr.13.1023, PubMed 24005696 -
No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy
Scand Cardiovasc J, 47 (2), 80-7
DOI 10.3109/14017431.2012.756119, PubMed 23301875 -
[Treatment with statins]
Tidsskr Nor Laegeforen, 133 (12-13), 1316-9
DOI 10.4045/tidsskr.12.0825, PubMed 23817262 -
Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotype
PLoS One, 8 (11), e78241
DOI 10.1371/journal.pone.0078241, PubMed 24244297 -
Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial
Circulation, 129 (2), 234-43
DOI 10.1161/CIRCULATIONAHA.113.007012, PubMed 24255061 -
Design and baseline data of a pediatric study with rosuvastatin in familial hypercholesterolemia
J Clin Lipidol, 7 (5), 408-13
DOI 10.1016/j.jacl.2013.06.010, PubMed 24079281 -
Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia
Expert Rev Cardiovasc Ther, 11 (8), 1061-6
DOI 10.1586/14779072.2013.814851, PubMed 23984929 -
Children and young adults with familial hypercholesterolaemia (FH) have healthier food choices particularly with respect to dietary fat sources compared with non-FH children
J Nutr Sci, 2, e32
DOI 10.1017/jns.2013.27, PubMed 25191582 -
Low level of inflammatory marker in hyperhomocysteinemic patients on statin therapy
Scand J Clin Lab Invest, 74 (1), 1-7
DOI 10.3109/00365513.2013.854926, PubMed 24236948 -
Phytosterol capsules and serum cholesterol in hypercholesterolemia: a randomized controlled trial
Atherosclerosis, 228 (2), 421-5
DOI 10.1016/j.atherosclerosis.2013.03.001, PubMed 23623012 -
UGT1A1*28 is associated with decreased systemic exposure of atorvastatin lactone
Mol Diagn Ther, 17 (4), 233-7
DOI 10.1007/s40291-013-0031-x, PubMed 23580084
Publications 2012
-
Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor-independent pathways
Transl Res, 160 (2), 125-30
DOI 10.1016/j.trsl.2012.01.010, PubMed 22683370 -
Safety of a fixed-dose combination of fenofibrate/pravastatin 160 mg/40 mg in patients with mixed hyperlipidaemia: a pooled analysis from a database of clinical trials
Clin Drug Investig, 32 (4), 281-91
DOI 10.2165/11630820-000000000-00000, PubMed 22350498 -
Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease
Diab Vasc Dis Res, 9 (3), 205-15
DOI 10.1177/1479164111430715, PubMed 22228773 -
Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis
BMC Med, 10, 33
DOI 10.1186/1741-7015-10-33, PubMed 22480336 -
Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia
J Clin Lipidol, 6 (4), 331-9
DOI 10.1016/j.jacl.2012.03.004, PubMed 22836070 -
Oxidized LDL level is related to gene expression of tumour necrosis factor super family members in children and young adults with familial hypercholesterolaemia
J Intern Med, 273 (1), 69-78
DOI 10.1111/j.1365-2796.2012.02584.x, PubMed 22891927 -
Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH
Thromb Res, 131 (2), 178-82
DOI 10.1016/j.thromres.2012.11.008, PubMed 23199546 -
LDL-apheresis affects markers of endothelial function in patients with homozygous familial hypercholesterolemia
Thromb Res, 130 (5), 823-5
DOI 10.1016/j.thromres.2012.06.004, PubMed 22728023 -
Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis
J Clin Lipidol, 7 (2), 109-16
DOI 10.1016/j.jacl.2012.08.001, PubMed 23415429 -
Elevated serum MMP-9/TIMP-1 ratio in patients with homozygous familial hypercholesterolemia: effects of LDL-apheresis
Cytokine, 61 (1), 194-8
DOI 10.1016/j.cyto.2012.09.016, PubMed 23131422 -
Intake of oxidised fish oil does not affect circulating levels of oxidised LDL or inflammatory markers in healthy subjects
Nutr Metab Cardiovasc Dis, 23 (1), e3-4
DOI 10.1016/j.numecd.2012.08.009, PubMed 23146358 -
[Omega-3 fatty acids--both food and medicine]
Tidsskr Nor Laegeforen, 132 (20), 2258
DOI 10.4045/tidsskr.12.1006, PubMed 23736186 -
Substitution of TAG oil with diacylglycerol oil in food items improves the predicted 10 years cardiovascular risk score in healthy, overweight subjects
J Nutr Sci, 1, e17
DOI 10.1017/jns.2012.18, PubMed 25191546
Publications 2011
-
Fixed-dose combination fenofibrate/pravastatin 160/40 mg versus simvastatin 20 mg monotherapy in adults with type 2 diabetes and mixed hyperlipidemia uncontrolled with simvastatin 20 mg: a double-blind, randomized comparative study
Clin Ther, 33 (1), 1-12
DOI 10.1016/j.clinthera.2011.02.006, PubMed 21397769 -
An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemia
Pediatr Cardiol, 32 (4), 433-41
DOI 10.1007/s00246-011-9885-z, PubMed 21259004 -
Sun exposure rapidly reduces plasmacytoid dendritic cells and inflammatory dermal dendritic cells in psoriatic skin
Br J Dermatol, 165 (4), 792-801
DOI 10.1111/j.1365-2133.2011.10430.x, PubMed 21623747 -
Paediatric screening for hypercholesterolaemia in Europe
Arch Dis Child, 97 (3), 272-6
DOI 10.1136/archdischild-2011-300081, PubMed 21949015 -
Effect of the fat composition of a single high-fat meal on inflammatory markers in healthy young women
Br J Nutr, 106 (12), 1826-35
DOI 10.1017/S0007114511002510, PubMed 21736782 -
Effect of marine n-3 fatty acids on circulating inflammatory markers in healthy subjects and subjects with cardiovascular risk factors
Inflamm Res, 60 (4), 309-19
DOI 10.1007/s00011-010-0302-5, PubMed 21229287 -
Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia
Atherosclerosis, 216 (2), 426-32
DOI 10.1016/j.atherosclerosis.2011.02.007, PubMed 21376325 -
Pitavastatin: finding its place in therapy
Ther Adv Chronic Dis, 2 (2), 101-17
DOI 10.1177/2040622310389227, PubMed 23251745 -
Oxidised fish oil does not influence established markers of oxidative stress in healthy human subjects: a randomised controlled trial
Br J Nutr, 108 (2), 315-26
DOI 10.1017/S0007114511005484, PubMed 22136711 -
Atorvastatin metabolite measurements as a diagnostic tool for statin-induced myopathy
Mol Diagn Ther, 15 (4), 221-7
DOI 10.1007/BF03256413, PubMed 21815705 -
[Assessment of dietary habits and life style]
Tidsskr Nor Laegeforen, 131 (5), 454
DOI 10.4045/tidsskr.10.0799, PubMed 21383795 -
Sun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis
Br J Dermatol, 164 (2), 344-55
DOI 10.1111/j.1365-2133.2010.10149.x, PubMed 21271993 -
Pregnancy outcomes in familial hypercholesterolemia: a registry-based study
Circulation, 124 (15), 1606-14
DOI 10.1161/CIRCULATIONAHA.110.990929, PubMed 21911783
Publications 2010
-
Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia
J Am Coll Cardiol, 55 (11), 1121-6
DOI 10.1016/j.jacc.2009.10.042, PubMed 20223367 -
HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled study
Scand Cardiovasc J, 44 (4), 197-200
DOI 10.3109/14017431003624123, PubMed 20636227 -
Analysis of LDLR mRNA in patients with familial hypercholesterolemia revealed a novel mutation in intron 14, which activates a cryptic splice site
J Hum Genet, 55 (10), 676-80
DOI 10.1038/jhg.2010.87, PubMed 20703241 -
[Clinical trials--viewpoints from participants]
Tidsskr Nor Laegeforen, 130 (16), 1606-8
DOI 10.4045/tidsskr.09.0030, PubMed 20805857 -
Children with familial hypercholesterolemia are characterized by an inflammatory imbalance between the tumor necrosis factor α system and interleukin-10
Atherosclerosis, 214 (1), 163-8
DOI 10.1016/j.atherosclerosis.2010.10.002, PubMed 21040915 -
Pitavastatin: a distinctive lipid-lowering drug
Clin. Lipidol., 5 (3), 309-323
DOI 10.2217/CLP.10.28 -
Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia (vol 210, pg 202, 2010)
Atherosclerosis, 212 (2), 704
DOI 10.1016/j.atherosclerosis.2010.05.023 -
Postradiotherapy plasma lutein, alpha-carotene, and beta-carotene are positively associated with survival in patients with head and neck squamous cell carcinoma
Nutr Cancer, 62 (3), 322-8
DOI 10.1080/01635580903441188, PubMed 20358469 -
Suggestive evidence of associations between liver X receptor β polymorphisms with type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA (France) and HELENA (Europe)
BMC Med Genet, 11, 144
DOI 10.1186/1471-2350-11-144, PubMed 20939869
Publications 2009
-
[Use of omega-3 fatty acids in the prevention of heart disease]
Tidsskr Nor Laegeforen, 129 (20), 2109-12
DOI 10.4045/tidsskr.08.0447, PubMed 19855449 -
Evidence for impaired physiological decrease in the uteroplacental vascular resistance in pregnant women with familial hypercholesterolemia
Acta Obstet Gynecol Scand, 88 (2), 222-6
DOI 10.1080/00016340802503047, PubMed 18972234 -
ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial
JAMA, 301 (11), 1131-9
DOI 10.1001/jama.301.11.1131, PubMed 19293413 -
Comparison of pitavastatin with simvastatin in primary hypercholesterolaemia or combined dyslipidaemia
Curr Med Res Opin, 25 (11), 2755-64
DOI 10.1185/03007990903290886, PubMed 19785568 -
Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia
Atherosclerosis, 210 (1), 202-8
DOI 10.1016/j.atherosclerosis.2009.12.009, PubMed 20080236 -
Effect of climate therapy at Gran Canaria on vitamin D production, blood glucose and lipids in patients with psoriasis
J Eur Acad Dermatol Venereol, 23 (10), 1133-40
DOI 10.1111/j.1468-3083.2009.03245.x, PubMed 19453805 -
Taspoglutide: a long acting human glucagon-like polypeptide-1 analogue
Expert Opin Investig Drugs, 18 (9), 1405-11
DOI 10.1517/13543780903164205, PubMed 19678802 -
Improved plasma lipids and body weight in overweight/obese patients with type III hyperlipoproteinemia after 4 weeks on a low glycemic diet
Clin Nutr, 28 (2), 213-5
DOI 10.1016/j.clnu.2009.01.018, PubMed 19232793 -
Cystatin C levels in plasma and peripheral blood mononuclear cells among hyperhomocysteinaemic subjects: effect of treatment with B-vitamins
Br J Nutr, 102 (12), 1783-9
DOI 10.1017/S0007114509991048, PubMed 19682403 -
Dairy products and metabolic effects in overweight men and women: results from a 6-mo intervention study
Am J Clin Nutr, 90 (4), 960-8
DOI 10.3945/ajcn.2009.27664, PubMed 19710195
Publications 2008
-
Rosuvastatin reduces non-high-density lipoprotein cholesterol and lipoprotein remnants in patients with dysbetalipoproteinemia (Fredrickson type III hyperlipoproteinemia)
J Clin Lipidol, 2 (6), 418-25
DOI 10.1016/j.jacl.2008.10.002, PubMed 21291775 -
[Severe hypertriglyceridemia--an important cause of pancreatitis]
Tidsskr Nor Laegeforen, 128 (9), 1053-6
PubMed 18451886 -
The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjects
J Nutr, 138 (11), 2070-5
DOI 10.3945/jn.108.090704, PubMed 18936200 -
[Can cardiovascular events be prevented by raising HDL cholesterol?]
Tidsskr Nor Laegeforen, 128 (13), 1519-23
PubMed 18587459 -
Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening
Community Genet, 11 (1), 26-35
DOI 10.1159/000111637, PubMed 18196915 -
Dysregulated RANK ligand/RANK axis in hyperhomocysteinemic subjects: effect of treatment with B-vitamins
Stroke, 40 (1), 241-7
DOI 10.1161/STROKEAHA.108.522995, PubMed 19008470 -
The real code of leonardo da vinci
Curr Cardiol Rev, 4 (1), 60-2
DOI 10.2174/157340308783565401, PubMed 19924278 -
[The zero vision for arteriosclerotic cardiovascular disease in younger people]
Tidsskr Nor Laegeforen, 128 (10), 1188-90
PubMed 18480870 -
Lipid lowering treatment patterns and goal attainment in Nordic patients with hyperlipidemia
Scand Cardiovasc J, 42 (4), 279-87
DOI 10.1080/14017430802073073, PubMed 18609053
Publications 2007
-
[Practical advice for registration of clinical trials]
Tidsskr Nor Laegeforen, 127 (12), 1654-6
PubMed 17571106 -
Efficacy and safety of ezetimibe/simvastatin versus simvastatin monotherapy in hypercholesterolemic patients with metabolic syndrome
Metab Syndr Relat Disord, 5 (1), 13-21
DOI 10.1089/met.2006.0033, PubMed 18370810 -
Experiences of guilt and shame in patients with familial hypercholesterolemia: a qualitative interview study
Patient Educ Couns, 69 (1-3), 108-13
DOI 10.1016/j.pec.2007.08.001, PubMed 17889493 -
[Lipid profile in children and adolescents with familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 127 (18), 2363-6
PubMed 17895939 -
Body composition, lipid and lipoprotein levels in childhood-onset systemic lupus erythematosus
Scand J Rheumatol, 36 (1), 40-7
DOI 10.1080/03009740600907881, PubMed 17454934 -
A multi-centre, randomised, double-blind 14-week extension study examining the long-term safety and efficacy profile of the ezetimibe/simvastatin combination tablet
Int J Clin Pract, 61 (9), 1469-80
DOI 10.1111/j.1742-1241.2007.01402.x, PubMed 17655686 -
Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques
Clin Ther, 29 (11), 2419-32
DOI 10.1016/j.clinthera.2007.10.004, PubMed 18158082 -
Further reduction of low-density lipoprotein cholesterol and C-reactive protein with the addition of ezetimibe to maximum-dose rosuvastatin in patients with severe hypercholesterolemia
J Clin Lipidol, 1 (4), 280-6
DOI 10.1016/j.jacl.2007.07.003, PubMed 21291692 -
The dual peroxisome proliferator-activated receptor alpha/gamma agonist tesaglitazar further improves the lipid profile in dyslipidemic subjects treated with atorvastatin
Metabolism, 56 (9), 1285-92
DOI 10.1016/j.metabol.2007.05.003, PubMed 17697874
Publications 2006
-
Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia
Atherosclerosis, 189 (2), 451-7
DOI 10.1016/j.atherosclerosis.2006.01.002, PubMed 16466729 -
Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia
Thromb Res, 120 (1), 21-7
DOI 10.1016/j.thromres.2006.07.001, PubMed 16914186 -
Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy
Arterioscler Thromb Vasc Biol, 26 (5), 1094-100
DOI 10.1161/01.ATV.0000204337.81286.1c, PubMed 16424354 -
Perceived vulnerability to heart disease in patients with familial hypercholesterolemia: a qualitative interview study
Ann Fam Med, 4 (3), 198-204
DOI 10.1370/afm.529, PubMed 16735520 -
Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy
Clin Pharmacol Ther, 79 (6), 532-9
DOI 10.1016/j.clpt.2006.02.014, PubMed 16765141 -
Enhanced platelet activation in hyperhomocysteinemic individuals
J Thromb Haemost, 5 (1), 193-5
DOI 10.1111/j.1538-7836.2006.02275.x, PubMed 17059422 -
Increased levels of C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects
Scand J Clin Lab Invest, 66 (1), 45-54
DOI 10.1080/00335510500429821, PubMed 16464786 -
Impaired inhibitory effect of interleukin-10 on the balance between matrix metalloproteinase-9 and its inhibitor in mononuclear cells from hyperhomocysteinemic subjects
Stroke, 37 (7), 1731-6
DOI 10.1161/01.STR.0000226465.84561.cb, PubMed 16728689 -
Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis
Curr Med Res Opin, 22 (5), 823-35
DOI 10.1185/030079906X100131, PubMed 16709304 -
Lipid management and cholesterol goal attainment in Norway
Am J Cardiovasc Drugs, 6 (2), 121-8
DOI 10.2165/00129784-200606020-00006, PubMed 16555865 -
Triglyceride-rich HDL3 from patients with familial hypercholesterolemia are less able to inhibit cytokine release or to promote cholesterol efflux
J Nutr, 136 (4), 877-81
DOI 10.1093/jn/136.4.877, PubMed 16549444 -
Increased inflammatory markers in children with familial hypercholesterolaemia
Eur J Clin Invest, 36 (3), 147-52
DOI 10.1111/j.1365-2362.2006.01613.x, PubMed 16506958
Publications 2005
-
Altered composition of HDL3 in FH subjects causing a HDL subfraction with less atheroprotective function
Clin Chim Acta, 359 (1-2), 171-8
DOI 10.1016/j.cccn.2005.03.050, PubMed 15936009 -
Post-radiotherapy plasma total glutathione is associated to outcome in patients with head and neck squamous cell carcinoma
Cancer Lett, 238 (2), 240-7
DOI 10.1016/j.canlet.2005.07.027, PubMed 16157445 -
Chemokines in children with heterozygous familiar hypercholesterolemia: selective upregulation of RANTES
Arterioscler Thromb Vasc Biol, 26 (1), 200-5
DOI 10.1161/01.ATV.0000193619.67288.ed, PubMed 16254204 -
Too low blood cholesterol?
Scand J Clin Lab Invest, 65 (1), 1-2
DOI 10.1080/00365510510013488, PubMed 15859021 -
[Does folic acid have effects on other health problems than neural tube defects?]
Tidsskr Nor Laegeforen, 125 (4), 438-41
PubMed 15742017 -
[Effects of public initiatives aimed at reducing neural tube defects with folic acid supplementation]
Tidsskr Nor Laegeforen, 125 (4), 435-7
PubMed 15742016 -
ELOVL3 is an important component for early onset of lipid recruitment in brown adipose tissue
J Biol Chem, 281 (8), 4958-68
DOI 10.1074/jbc.M511588200, PubMed 16326704
Publications 2004
-
Long-term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with FH consuming plant sterol ester-enriched spread
Eur J Clin Nutr, 58 (12), 1612-20
DOI 10.1038/sj.ejcn.1602015, PubMed 15199384 -
A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia
Clin Ther, 26 (11), 1758-73
DOI 10.1016/j.clinthera.2004.11.016, PubMed 15639688 -
Psychological factors and cardiovascular disease
J Thromb Haemost, 2 (1), 201-3
DOI 10.1111/j.1538-7836.2004.0562g.x, PubMed 14717990 -
[Hypertriglyceridemia--diagnostics, risk and treatment]
Tidsskr Nor Laegeforen, 124 (21), 2746-9
PubMed 15534665 -
[A family-based strategy for diagnosing familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 124 (9), 1228-9
PubMed 15131703 -
Diagnostic, clinical, and therapeutic aspects of familial hypercholesterolemia in children
Semin Vasc Med, 4 (1), 51-7
DOI 10.1055/s-2004-822986, PubMed 15199433 -
Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans
J Nutr, 134 (3), 562-7
DOI 10.1093/jn/134.3.562, PubMed 14988447 -
Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors
Circulation, 109 (16), 1966-72
DOI 10.1161/01.CIR.0000125700.33637.B1, PubMed 15051633
Publications 2003
-
Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups
Clin Cardiol, 26 (11), 509-14
DOI 10.1002/clc.4960261106, PubMed 14640465 -
[Shortcomings and strength of practice guidelines]
Tidsskr Nor Laegeforen, 123 (11), 1566-7
PubMed 12822025 -
CXC-chemokines in coronary artery disease: possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cells
J Thromb Haemost, 1 (2), 257-62
DOI 10.1046/j.1538-7836.2003.00065.x, PubMed 12871498 -
Expression of matrix metalloproteinase-9 in mononuclear cells of hyperhomocysteinaemic subjects
Eur J Clin Invest, 33 (7), 555-60
DOI 10.1046/j.1365-2362.2003.01189.x, PubMed 12814391 -
Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects
Br J Nutr, 89 (3), 359-63
DOI 10.1079/BJN2002779, PubMed 12628031 -
Patients with familial hypercholesterolaemia show enhanced spontaneous chemokine release from peripheral blood mononuclear cells ex vivo. Dependency of xanthomas/xanthelasms, smoking and gender
Eur Heart J, 24 (19), 1756-62
DOI 10.1016/s0195-668x(03)00467-6, PubMed 14522571 -
Hyperhomocysteinemic subjects have enhanced expression of lectin-like oxidized LDL receptor-1 in mononuclear cells
J Nutr, 133 (11), 3588-91
DOI 10.1093/jn/133.11.3588, PubMed 14608078 -
Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial
J Pediatr, 143 (1), 74-80
DOI 10.1016/S0022-3476(03)00186-0, PubMed 12915827
Publications 2002
-
Plant sterol ester-enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia
Am J Clin Nutr, 76 (2), 338-44
DOI 10.1093/ajcn/76.2.338, PubMed 12145004 -
Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin
Circulation, 106 (17), 2231-7
DOI 10.1161/01.cir.0000035247.42888.82, PubMed 12390953 -
[Guidelines for pharmacological primary prevention of cardiovascular diseases--who should be treated?]
Tidsskr Nor Laegeforen, 122 (23), 2277-81
PubMed 12448268 -
[Which antihypertensive drugs should be used in the primary prevention of cardiovascular disease?]
Tidsskr Nor Laegeforen, 122 (23), 2283-6
PubMed 12448269 -
[Which cholesterol-lowering drugs should be used in the primary prevention of cardiovascular disease?]
Tidsskr Nor Laegeforen, 122 (23), 2287-8
PubMed 12448270 -
Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects
Arterioscler Thromb Vasc Biol, 22 (4), 699-703
DOI 10.1161/01.atv.0000013288.35930.90, PubMed 11950713 -
Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia
Am Heart J, 144 (6), 1044-51
DOI 10.1067/mhj.2002.128049, PubMed 12486429 -
[Müller-Harbitz disease--familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 122 (9), 924-5
PubMed 12082837 -
Familial hypercholesterolemia from children to adults
Cardiovasc Drugs Ther, 16 (4), 289-93
DOI 10.1023/a:1021773724477, PubMed 12652097 -
Reproducibility and validity of a short food questionnaire for the assessment of dietary habits
Nutr Metab Cardiovasc Dis, 12 (2), 60-70
PubMed 12189905
Publications 2001
-
[Transesophageal echocardiography at a small Norwegian district hospital]
Tidsskr Nor Laegeforen, 121 (5), 572-4
PubMed 11301612 -
Disposition of homocysteine in subjects heterozygous for homocystinuria due to cystathionine beta-synthase deficiency: relationship between genotype and phenotype
Am J Med Genet, 100 (3), 204-13
DOI 10.1002/ajmg.1247, PubMed 11343305 -
Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects
Am J Med, 110 (7), 536-42
DOI 10.1016/s0002-9343(01)00696-9, PubMed 11343667 -
Fine mapping of a gene responsible for regulating dietary cholesterol absorption; founder effects underlie cases of phytosterolaemia in multiple communities
Eur J Hum Genet, 9 (5), 375-84
DOI 10.1038/sj.ejhg.5200628, PubMed 11378826 -
[Familial hypercholesterolemia--prognosis and treatment]
Tidsskr Nor Laegeforen, 121 (13), 1635
PubMed 11446054 -
[Genetic screening and treatment in familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 121 (13), 1635-6
PubMed 11446055 -
Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively
Am J Hum Genet, 69 (2), 278-90
DOI 10.1086/321294, PubMed 11452359 -
[Treatment goals for blood lipids in high risk patients of atherosclerotic disease]
Tidsskr Nor Laegeforen, 121 (9), 1059-63
PubMed 11354882 -
Serum cholesterol response to replacing butter with a new trans-free margarine in hypercholesterolemic subjects
Nutr Metab Cardiovasc Dis, 11 (5), 320-6
PubMed 11887429 -
Differences in the conversion of the polyunsaturated fatty acids [1-(14)C]22:4(n-6) and [1-(14)C]22:5(n-3) to [(14)C]22:5(n-6) and [(14)C]22:6(n-3) in isolated rat hepatocytes
Biochim Biophys Acta, 1532 (1-2), 137-47
DOI 10.1016/s1388-1981(01)00127-5, PubMed 11420183
Publications 2000
-
[Cardiologic procedures at a smaller Norwegian hospital--educational potential for assistant residents]
Tidsskr Nor Laegeforen, 120 (18), 2192
PubMed 11006748 -
A functional polymorphism in the promoter region of the microsomal triglyceride transfer protein (MTP -493G/T) influences lipoprotein phenotype in familial hypercholesterolemia
Arterioscler Thromb Vasc Biol, 20 (7), 1784-8
DOI 10.1161/01.atv.20.7.1784, PubMed 10894817 -
Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia
Nutr Metab Cardiovasc Dis, 10 (5), 253-62
PubMed 11213534 -
Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels
Am J Cardiol, 86 (2), 221-3
DOI 10.1016/s0002-9149(00)00942-5, PubMed 10913488 -
Effect of Norwegian fish powder on risk factors for coronary heart disease among hypercholesterolemic individuals
Nutr Metab Cardiovasc Dis, 10 (6), 323-30
PubMed 11302007 -
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group
Clin Cardiol, 23 (1), 39-46
DOI 10.1002/clc.4960230108, PubMed 10680028 -
Cerivastatin gender effect: sub-analyses of results from a multinational, randomised, double-blind study. Cerivastatin Study Group
Curr Med Res Opin, 16 (2), 80-7
PubMed 10893651 -
[The diet of patients with atherosclerotic disease compared with the standard diet in the population]
Tidsskr Nor Laegeforen, 120 (22), 2618-24
PubMed 11077504 -
Lipid treatment goals achieved in patients treated with statin drugs in Norwegian general practice
Am J Cardiol, 86 (11), 1250-3, A6
DOI 10.1016/s0002-9149(00)01212-1, PubMed 11090801 -
Application of simple lipid treatment goals in patients with atherosclerotic disease
Nutr Metab Cardiovasc Dis, 10 (2), 71-8
PubMed 10919171 -
Does maternal or paternal heredity affect carotid atherosclerosis in children with familial hypercholesterolaemia?
Acta Paediatr, 89 (12), 1490-2
DOI 10.1080/080352500456705, PubMed 11195242
Publications 1999
-
Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I
Am J Cardiol, 83 (10), 1476-7, A7
DOI 10.1016/s0002-9149(99)00153-8, PubMed 10335764 -
Efficacy and safety of 300 micrograms and 400 micrograms cerivastatin once daily in patients with primary hypercholesterolaemia: a multicentre, randomized, double-blind, placebo-controlled study
J Int Med Res, 27 (3), 115-29
DOI 10.1177/030006059902700302, PubMed 10505301 -
Retinoylation of proteins in rat hepatocytes following uptake of chylomicron remnant retinyl ester
Scand J Clin Lab Invest, 59 (5), 315-24
DOI 10.1080/00365519950185508, PubMed 10533843 -
An update on familial hypercholesterolaemia
Ann Med, 31 Suppl 1, 13-8
PubMed 10342495 -
An update on familial hypercholesterolaemia
Ann Med, 31 (sup1), 13-18
DOI 10.1080/07853890.1999.11904394, PubMed 28850282 -
Efficacy and safety of cerivastatin, 0.2 mg and 0.4 mg, in patients with primary hypercholesterolaemia: a multinational, randomised, double-blind study. Cerivastatin Study Group
Curr Med Res Opin, 15 (3), 228-40
DOI 10.1185/03007999909114095, PubMed 10621930 -
Phenotypic consequences of a deletion of exons 2 and 3 of the LDL receptor gene
J Lipid Res, 40 (2), 213-20
PubMed 9925649 -
Mutant transcripts of the LDL receptor gene: mRNA structure and quantity
Hum Mutat, 13 (3), 186-96
DOI 10.1002/(SICI)1098-1004(1999)13:3<186::AID-HUMU2>3.0.CO;2-K, PubMed 10090473 -
Under-reporting of dietary intake by smoking and non-smoking subjects counselled for hypercholesterolaemia
J Intern Med, 245 (4), 337-44
DOI 10.1046/j.1365-2796.1999.00450.x, PubMed 10356595
Publications 1998
-
Clinical efficacy and safety of cerivastatin: summary of pivotal phase IIb/III studies
Am J Cardiol, 82 (4B), 32J-39J
DOI 10.1016/s0002-9149(98)00435-4, PubMed 9737644 -
Efficacy and six-month safety of simvastatin 80 mg/day: Results from the worldwide simvastatin expanded dose program (WSEDP)
Nutr. Metab. Carbiovasc. Dis., 8 (3), 135-143 -
[Attitude to genetic screening for familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 118 (10), 1578-81
PubMed 9615587 -
Effects of a 9.6-kb deletion of the LDL receptor gene (FH Helsinki) on structure and levels of mRNA
Hum Mutat, 12 (2), 95-102
DOI 10.1002/(SICI)1098-1004(1998)12:2<95::AID-HUMU4>3.0.CO;2-E, PubMed 9671270 -
[Referrals to the Lipid clinic--"appropriate" patients with inadequate anamnesis]
Tidsskr Nor Laegeforen, 118 (5), 749-52
PubMed 9528374 -
Carotid intima-media thickness and plaque in patients with familial hypercholesterolaemia mutations and control subjects
Eur J Clin Invest, 28 (12), 971-9
DOI 10.1046/j.1365-2362.1998.00399.x, PubMed 9893006 -
The C677T mutation in the methylenetetrahydrofolate reductase gene predisposes to hyperhomocysteinemia in children with familial hypercholesterolemia treated with cholestyramine
J Pediatr, 132 (2), 365-8
DOI 10.1016/s0022-3476(98)70465-2, PubMed 9506661 -
Expression of retinoic acid receptor and retinoid X receptor subtypes in rat liver cells: implications for retinoid signalling in parenchymal, endothelial, Kupffer and stellate cells
Eur J Cell Biol, 77 (2), 111-6
DOI 10.1016/S0171-9335(98)80078-2, PubMed 9840460 -
Monounsaturated trans fatty acids, elaidic acid and trans-vaccenic acid, metabolism and incorporation in phospholipid molecular species in hepatocytes
Scand J Clin Lab Invest, 58 (8), 635-45
DOI 10.1080/00365519850186067, PubMed 10088200
Publications 1997
-
Functional modeling of vitamin responsiveness in yeast: a common pyridoxine-responsive cystathionine beta-synthase mutation in homocystinuria
Hum Mol Genet, 6 (13), 2213-21
DOI 10.1093/hmg/6.13.2213, PubMed 9361025 -
Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I
J Lipid Res, 38 (1), 121-31
PubMed 9034206 -
[Application of gene technology in the diagnosis of familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 117 (5), 678-81
PubMed 9102960 -
[Is there a need for genetic/molecular diagnosis of familial hypercholesterolemia?]
Tidsskr Nor Laegeforen, 117 (5), 681-3
PubMed 9102961 -
Molecular genetics of familial hypercholesterolaemia in Norway
J Intern Med, 241 (3), 185-94
DOI 10.1046/j.1365-2796.1997.78119000.x, PubMed 9104431 -
Storage of vitamin A in extrahepatic stellate cells in normal rats
J Lipid Res, 38 (4), 645-58
PubMed 9144080 -
[What happens with patients after participation in a clinical trial?]
Tidsskr Nor Laegeforen, 117 (28), 4065-9
PubMed 9441437 -
[Drug therapy of hyperlipidemia--unanswered questions]
Tidsskr Nor Laegeforen, 117 (5), 674-7
PubMed 9102959 -
Correlates of plasma total homocysteine in patients with hyperlipidaemia
Eur J Clin Invest, 27 (12), 1025-9
DOI 10.1046/j.1365-2362.1997.2260772.x, PubMed 9466131 -
[Diagnosis and treatment of severe hyperlipidemia]
Tidsskr Nor Laegeforen, 117 (29), 4241-4
PubMed 9441469 -
Association between plasma total homocysteine and parental history of cardiovascular disease in children with familial hypercholesterolemia
Circulation, 96 (6), 1803-8
DOI 10.1161/01.cir.96.6.1803, PubMed 9323065 -
Flow cytometric measurement of low density lipoprotein receptor activity validated by DNA analysis in diagnosing heterozygous familial hypercholesterolemia
Cytometry, 30 (5), 264-8
PubMed 9383100
Publications 1996
-
Two novel missense mutations in the LDL receptor gene causing familial hypercholesterolemia
Clin Genet, 49 (2), 85-7
DOI 10.1111/j.1399-0004.1996.tb04333.x, PubMed 8740918 -
Effect of homocysteine on copper ion-catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein
J Lipid Res, 37 (7), 1591-600
PubMed 8827529 -
Screening for known mutations in the LDL receptor gene causing familial hypercholesterolemia (vol 95, pg 671, 1995)
Hum. Genet., 97 (2), 268
DOI 10.1007/BF02265281 -
Phytosterolaemia in a Norwegian family: diagnosis and characterization of the first Scandinavian case
Scand J Clin Lab Invest, 56 (3), 229-40
DOI 10.3109/00365519609088612, PubMed 8761527 -
The C-terminal RNLL sequence of the plasma retinol-binding protein is not responsible for its intracellular retention
Biochem Biophys Res Commun, 221 (2), 374-9
DOI 10.1006/bbrc.1996.0603, PubMed 8619863 -
Effect of hormone replacement therapy on the susceptibility of low-density lipoprotein to oxidation among postmenopausal hypercholesterolaemic women
Eur J Clin Invest, 26 (12), 1062-8
DOI 10.1046/j.1365-2362.1996.390593.x, PubMed 9013080 -
Simvastatin-fluvastatin comparative study - Reply
Clin. Drug Invest., 11 (6), 363-364 -
Simvastatin-fluvastatin comparative study - Continued - Reply
Clin. Drug Invest., 12 (1), 57 -
Results of intensive long-term treatment of familial hypercholesterolemia
Am J Cardiol, 78 (12), 1369-74
DOI 10.1016/s0002-9149(96)00649-2, PubMed 8970408 -
A common missense mutation (C210G) in the LDL receptor gene among Norwegian familial hypercholesterolemia subjects
Hum Mutat, 7 (1), 70-1
DOI 10.1002/(SICI)1098-1004(1996)7:1<70::AID-HUMU12>3.0.CO;2-P, PubMed 8664907 -
Familial hypercholesterolaemia: a pilot study of parents' and children's concerns
Acta Paediatr, 85 (11), 1307-13
DOI 10.1111/j.1651-2227.1996.tb13916.x, PubMed 8955457 -
Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects
Arterioscler Thromb Vasc Biol, 16 (8), 984-91
DOI 10.1161/01.atv.16.8.984, PubMed 8696963 -
Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia
J Pediatr, 129 (1), 42-9
DOI 10.1016/s0022-3476(96)70188-9, PubMed 8757561 -
Colestipol tablets in adolescents with familial hypercholesterolaemia
Acta Paediatr, 85 (9), 1080-2
DOI 10.1111/j.1651-2227.1996.tb14221.x, PubMed 8888922 -
Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives
Pediatr Res, 40 (1), 47-52
DOI 10.1203/00006450-199607000-00009, PubMed 8798245 -
Low dose colestipol in adolescents with familial hypercholesterolaemia
Arch Dis Child, 74 (2), 157-60
DOI 10.1136/adc.74.2.157, PubMed 8660081 -
The effect of growth hormone on low-density lipoprotein cholesterol and lipoprotein (a) levels in familial hypercholesterolemia
Metabolism, 45 (11), 1415-21
DOI 10.1016/s0026-0495(96)90124-9, PubMed 8931648
Publications 1995
-
Comparison of the effect of fluvastatin, an hydroxymethyl glutaryl coenzyme A reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by apolipoprotein composition
Metabolism, 44 (11), 1447-54
DOI 10.1016/0026-0495(95)90145-0, PubMed 7476333 -
Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group
Am J Cardiol, 76 (2), 65A-70A
DOI 10.1016/s0002-9149(05)80021-9, PubMed 7604802 -
CHANGES IN PLASMA APOLIPOPROTEIN B-CONTAINING LIPOPARTICLE LEVELS FOLLOWING THERAPY WITH FLUVASTATIN AND CHOLESTYRAMINE
Am. J. Cardiol., 76 (2), A65-A70 -
[Diet and lipid status in pregnant women]
Tidsskr Nor Laegeforen, 115 (11), 1358-60
PubMed 7770831 -
Identification of the apo B-3500 mutation in the Norwegian population
Scand J Clin Lab Invest, 55 (3), 217-21
DOI 10.3109/00365519509089616, PubMed 7638555 -
Two novel point mutations in the EGF precursor homology domain of the LDL receptor gene causing familial hypercholesterolemia
Hum Genet, 96 (2), 241-2
DOI 10.1007/BF00207391, PubMed 7635482 -
Screening for known mutations in the LDL receptor gene causing familial hypercholesterolemia
Hum Genet, 95 (6), 671-6
DOI 10.1007/BF00209485, PubMed 7789953 -
Standardization of a flow cytometric method for measurement of low-density lipoprotein receptor activity on blood mononuclear cells
Cytometry, 20 (4), 290-5
DOI 10.1002/cyto.990200404, PubMed 7587716 -
No effect of beta-carotene supplementation on the susceptibility of low density lipoprotein to in vitro oxidation among hypercholesterolaemic, postmenopausal women
Scand J Clin Lab Invest, 55 (6), 477-85
DOI 10.3109/00365519509075385, PubMed 8571077 -
FIRST ANNUAL COPENHAGEN ATHEROSCLEROSIS CONFERENCE
Arterioscl. Thromb. Vasc. Biol., 15 (10), 1787-1790 -
[Treatment of hyperlipidemia. Guidelines for treatment of hyperlipidemia for secondary prevention of ischemic heart disease]
Tidsskr Nor Laegeforen, 115 (29), 3629-31
PubMed 8539720 -
Erratum to Double-blind comparison of the efficacy and tolerability of simvastatin and fluvastatin in patients with primary hypercholesterolaemia
Clin Drug Investig, 10 (6), 343
DOI 10.1007/BF03259374, PubMed 27519335 -
Double-Blind Comparison of the Efficacy and Tolerability of Simvastatin and Fluvastatin in Patients with Primary Hypercholesterolaemia
Clin Drug Investig, 10 (3), 127-38
DOI 10.2165/00044011-199510030-00001, PubMed 27519196 -
[Familial hypercholesterolemia in children. A management program. Procedures for diagnosis and treatment in our pediatric departments]
Tidsskr Nor Laegeforen, 115 (28), 3514
PubMed 7491607 -
The detection and management of dyslipidaemia in children and adolescents
Acta Paediatr, 84 (11), 1213-5
PubMed 8580613 -
[Diagnosis and treatment of familial hypercholesterolemia in children and adolescents]
Tidsskr Nor Laegeforen, 115 (28), 3499-503
PubMed 7491603 -
[A rapid analysis of the lipid profile. A comparative study of different analytical methods for determination of blood lipids]
Tidsskr Nor Laegeforen, 115 (28), 3487-9
PubMed 7491599 -
Effect of large-volume liposuction on sex hormones and glucose- and lipid metabolism in females
Aesthetic Plast Surg, 19 (2), 131-5
DOI 10.1007/BF00450248, PubMed 7598023 -
A novel variant of lysosomal acid lipase (Leu336-->Pro) associated with acid lipase deficiency and cholesterol ester storage disease
Arterioscler Thromb Vasc Biol, 15 (6), 773-8
DOI 10.1161/01.atv.15.6.773, PubMed 7773732 -
[Antioxidants and cardiovascular disorders--epidemiologic aspects. Should high risk patients receive supplementation?]
Tidsskr Nor Laegeforen, 115 (2), 227-9
PubMed 7855818 -
EFFECTIVENESS OF COLESTIPOL TABLETS VS GRANULES IN PATIENTS WITH MODERATE TO SEVERE HYPERCHOLESTEROLEMIA
Clin. Drug Invest., 10 (5), 257-263
DOI 10.2165/00044011-199510050-00002 -
PHYSICAL-FITNESS AND FIBRINOGEN LEVELS AMONG HYPERCHOLESTEROLEMIC POSTMENOPAUSAL WOMEN
Nutr. Metab. Carbiovasc. Dis., 5 (2), 93-97 -
Is dietary intervention effective in post-transplant hyperlipidaemia?
Nephrol Dial Transplant, 10 (1), 82-5
PubMed 7724035 -
Determinants of lipid levels among children with heterozygous familial hypercholesterolemia in Norway
Arterioscler Thromb Vasc Biol, 15 (8), 1009-14
DOI 10.1161/01.atv.15.8.1009, PubMed 7627689 -
Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women
J Intern Med, 238 (1), 39-47
DOI 10.1111/j.1365-2796.1995.tb00897.x, PubMed 7608645 -
Screening for familial hypercholesterolaemia in relatives
Lancet, 346 (8987), 1438
DOI 10.1016/s0140-6736(95)92461-2, PubMed 7475864
Publications 1994
-
[Diet therapy of hypercholesterolemia. Can the diet of persons who already follow a cholesterol-lowering diet be further improved by guidelines given by a clinical nutritionist?]
Tidsskr Nor Laegeforen, 114 (18), 2106-8
PubMed 7992266 -
[Iron status in postmenopausal women]
Tidsskr Nor Laegeforen, 114 (4), 436-8
PubMed 8009479 -
Fluvastatin efficacy and tolerability in comparison and in combination with cholestyramine
Eur J Clin Pharmacol, 46 (5), 445-9
DOI 10.1007/BF00191909, PubMed 7957541 -
Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjects
Atherosclerosis, 111 (2), 175-82
DOI 10.1016/0021-9150(94)90091-4, PubMed 7718019 -
Modification of low density lipoprotein in relation to intake of fatty acids and antioxidants
World Rev Nutr Diet, 75, 144-8
DOI 10.1159/000423570, PubMed 7871817 -
Familial hypercholesterolaemia caused by a non-sense mutation in codon 329 of the LDL receptor gene
Scand J Clin Lab Invest, 54 (8), 605-9
DOI 10.3109/00365519409087539, PubMed 7709162 -
[A comparison between lovastatin and pravastatin--effects on lipids, sleep and quality of life in primary hyperlipidemia]
Tidsskr Nor Laegeforen, 114 (19), 2262-4
PubMed 7992293 -
The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia
Eur J Clin Pharmacol, 46 (5), 405-10
DOI 10.1007/BF00191901, PubMed 7957533 -
RESPONSIVENESS TO DIETARY INDULGENCE AMONG PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
Nutr. Metab. Carbiovasc. Dis., 4 (3), 159-162
Publications 1993
-
A MULTICENTER COMPARATIVE TRIAL OF LOVASTATIN AND PRAVASTATIN IN THE TREATMENT OF HYPERCHOLESTEROLEMIA
Am. J. Cardiol., 71 (10), 810-815 -
[Apolipoprotein E phenotyping--useful in the study of hyperlipoproteinemia type III]
Tidsskr Nor Laegeforen, 113 (7), 853-6
PubMed 8480294 -
Evaluation of running conditions for SSCP analysis: application of SSCP for detection of point mutations in the LDL receptor gene
PCR Methods Appl, 3 (3), 159-62
DOI 10.1101/gr.3.3.159, PubMed 8118396 -
Screening for point mutations in exon 10 of the low density lipoprotein receptor gene by analysis of single-strand conformation polymorphisms: detection of a nonsense mutation-FH469-->Stop
Hum Genet, 92 (1), 6-10
DOI 10.1007/BF00216137, PubMed 8103503 -
Haplotype analysis at the low density lipoprotein receptor locus in normal and familial hypercholesterolemia Norwegian subjects
Clin Genet, 44 (4), 214-20
DOI 10.1111/j.1399-0004.1993.tb03883.x, PubMed 7903228 -
MSPL RFLP IN EXON 18 OF THE LDL RECEPTOR GENE DETECTABLE BY PCR
Clin. Genet., 44 (2), 111 -
Short report on DNA marker at candidate locus
Clin Genet, 44 (2), 111
PubMed 8275559 -
Effectiveness of low-dose lovastatin combined with low-dose colestipol in moderate to severe primary hypercholesterolaemia
Scand J Clin Lab Invest, 53 (5), 457-63
DOI 10.1080/00365519309092540, PubMed 8210967
Publications 1992
-
Effects of dietary purified eicosapentaenoic acid (20:5 (n-3)) and docosahexaenoic acid (22:6(n-3)) on fatty acid desaturation and oxidation in isolated rat liver cells
Biochim Biophys Acta, 1125 (1), 35-43
DOI 10.1016/0005-2760(92)90152-l, PubMed 1533162 -
A new polymorphism in exon 11 of the LDL receptor gene in healthy people and in familial hypercholesterolemia subjects
Clin Genet, 42 (5), 224-8
DOI 10.1111/j.1399-0004.1992.tb03245.x, PubMed 1486698 -
[Triglycerides, HDL and coronary disease. Consensus conference: National Institutes of Health 1992]
Tidsskr Nor Laegeforen, 112 (21), 2768-71
PubMed 1412312 -
[Lovastatin in primary hypercholesterolemia. A Norwegian multicenter study]
Tidsskr Nor Laegeforen, 112 (29), 3665-9
PubMed 1471127 -
[Quality assurance in clinical trials. Problems related to patient information]
Tidsskr Nor Laegeforen, 112 (25), 3204-7
PubMed 1462295 -
Short-term effects of treatment with simvastatin on testicular function in patients with heterozygous familial hypercholesterolaemia
Eur J Clin Pharmacol, 42 (1), 61-4
DOI 10.1007/BF00314921, PubMed 1541317 -
A 9.6 kilobase deletion in the low density lipoprotein receptor gene in Norwegian familial hypercholesterolemia subjects
Clin Genet, 42 (6), 288-95
DOI 10.1111/j.1399-0004.1992.tb03258.x, PubMed 1362925 -
Uptake of chylomicron remnant retinyl esters in human leukocytes in vivo
Eur J Clin Invest, 22 (4), 229-34
DOI 10.1111/j.1365-2362.1992.tb01456.x, PubMed 1499639 -
[Familial hypercholesterolemia--intensive diet therapy combined with drug therapy]
Tidsskr Nor Laegeforen, 112 (20), 2642-6
PubMed 1412289
Publications 1991
-
[Treatment of hypercholesterolemia in adults. A treatment program 1991]
Tidsskr Nor Laegeforen, 111 (28), 3407-11
PubMed 1792668 -
Dietary n-6 fatty acids inhibit the incorporation of dietary n-3 fatty acids in thrombocyte and serum phospholipids in humans: a controlled dietetic study
Scand J Clin Lab Invest, 51 (3), 255-63
DOI 10.3109/00365519109091612, PubMed 1909049 -
Treatment with hydroxymethylglutaryl-coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system
Arterioscler Thromb, 11 (1), 138-45
DOI 10.1161/01.atv.11.1.138, PubMed 1987991 -
[Dietary supplementation in the treatment of hyperlipidemia]
Tidsskr Nor Laegeforen, 111 (28), 3398-400
PubMed 1665257
Publications 1990
-
[Identification of syndromes using a combined computer and video program]
Tidsskr Nor Laegeforen, 110 (9), 1085-7
PubMed 2184540 -
[Are prosecuted parents allowed the benefit of the doubt in cases of child abuse?]
Tidsskr Nor Laegeforen, 110 (5), 627-8
PubMed 2309218
Publications 1989
-
[Marketing of Carduran]
Tidsskr Nor Laegeforen, 109 (17-18), 1920-1
PubMed 2526393 -
[Drug therapy of hypercholesterolemia. Treatment of hypercholesterolemia in adults--a Norwegian therapeutic program 1988]
Tidsskr Nor Laegeforen, 109 (7-8), 850-2
PubMed 2705170 -
Familial hypercholesterolemia. 50 years of research
Arteriosclerosis, 9 (1 Suppl), I1-2
PubMed 2643426
Publications 1988
-
Effects of adrenaline on excitation-induced stimulation of the sodium-potassium pump in rat skeletal muscle
Acta Physiol Scand, 134 (2), 189-98
DOI 10.1111/j.1748-1716.1988.tb08479.x, PubMed 2852445 -
[Fraser's syndrome--cryptophthalmia]
Tidsskr Nor Laegeforen, 108 (25), 1998-9
PubMed 3144053 -
Computed tomography of a tuberculous paravertebral abscess
Z Kinderchir, 43 (6), 430-2
DOI 10.1055/s-2008-1044106, PubMed 3239258
Publications 1987
-
[Treatment of familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 107 (32), 2836-8, 2840
PubMed 3321550 -
[Cardiovascular diseases: we start with children]
Nord Med, 102 (10), 265-6
PubMed 3697042
Publications 1983
-
Autosomal dominant partial lipodystrophy associated with Rieger anomaly, short stature, and insulinopenic diabetes
Am J Med Genet, 15 (1), 29-38
DOI 10.1002/ajmg.1320150104, PubMed 6407320
Publications 1981
-
Intracellular degradation of 125I-labelled asialo-glycoproteins in rat hepatocytes: effect of leupeptin on subcellular distribution of asialo-fetuin
Int J Biochem, 13 (3), 253-9
DOI 10.1016/0020-711x(81)90076-8, PubMed 6163669 -
The binding of high density lipoproteins to isolated rat hepatocytes
Scand J Clin Lab Invest, 41 (1), 63-73
DOI 10.3109/00365518109092016, PubMed 7256194 -
Binding, uptake, and degradation of 125I-labelled high-density lipoproteins in isolated non-parenchymal rat liver cells
Scand J Gastroenterol, 16 (1), 71-80
PubMed 7233082
Publications 1980
-
The intracellular distribution of high density lipoproteins taken up by isolated rat hepatocytes
Biochim Biophys Acta, 620 (1), 120-32
DOI 10.1016/0005-2760(80)90191-5, PubMed 6251895 -
Fluid endocytosis in isolated rat parenchymal and non-parenchymal liver cells
Exp Cell Res, 126 (1), 109-19
DOI 10.1016/0014-4827(80)90475-9, PubMed 7188905 -
The effect of ammonia, chloroquine, leupeptin, colchicine and cytochalasin B on degradation of high density lipoproteins in isolated rat hepatocytes
Exp Cell Res, 130 (1), 127-35
DOI 10.1016/0014-4827(80)90049-x, PubMed 7192635 -
Catabolism of (125-I)low density lipoproteins in isolated rat liver cells
Biochem Biophys Res Commun, 97 (1), 192-9
DOI 10.1016/s0006-291x(80)80153-7, PubMed 7458932
Publications 1979
-
Uptake and degradation of 125I-labelled high density lipoproteins in rat liver cells in vivo and in vitro
Biochim Biophys Acta, 574 (3), 521-36
DOI 10.1016/0005-2760(79)90248-0, PubMed 226159
Publications 1977
-
A heritable syndrome of craniosynostosis, short thin hair, dental abnormalities, and short limbs: cranioectodermal dysplasia
J Pediatr, 90 (1), 55-61
DOI 10.1016/s0022-3476(77)80764-6, PubMed 830894 -
Hyperlipidemia: clinical clues in the first two decades of life
Johns Hopkins Med J, 140 (4), 171-6
PubMed 850334 -
[Hyperlipemia in children]
Tidsskr Nor Laegeforen, 97 (2), 67-73
PubMed 835105 -
Prophylactiv use of propranolol in the Marfan syndrome to prevent aortic dissection
Birth Defects Orig Artic Ser, 13 (3C), 163-9
PubMed 19114
Publications 1976
-
Circulating dopamine-beta-hydroxylase (DbetaH) and catecholamines in a paediatric phaeochromocytoma
Clin Exp Pharmacol Physiol, 3 (5), 487-91
DOI 10.1111/j.1440-1681.1976.tb00627.x, PubMed 975634 -
Letter: Usefulness of the xylose test for coeliac disease
Arch Dis Child, 51 (5), 400-1
DOI 10.1136/adc.51.5.400, PubMed 938086 -
Serum beta-lipoprotein subfractions in polyacrylamide gel electrophoresis associated with coronary heart disease
Scand J Clin Lab Invest, 36 (1), 75-9
DOI 10.1080/00365517609068021, PubMed 176718 -
Neonatal osteomyelitis caused by group B streptococci
Scand J Infect Dis, 8 (3), 219-21
DOI 10.3109/inf.1976.8.issue-3.20, PubMed 788147
Publications 1975
-
[Finnish families in the town of Sør-Varanger. II. A study of blood pressure, height, weight, cholesterol, triglycerides and lipoprotein electrophoresis among Finnish men - combined effects of a change in diet]
Sykepleien, 62 (16), 728-35
PubMed 1043245 -
Letter: L.D.L. and total cholesterol in cord-blood screening for familial hypercholesterolaemia
Lancet, 2 (7935), 615-6
DOI 10.1016/s0140-6736(75)90216-0, PubMed 51449 -
[Encephalitis associated with mycoplasma pneumoniae infection in children]
Tidsskr Nor Laegeforen, 95 (12), 756-8,779
PubMed 1145545 -
Neonatal screening for hyperlipidaemia
Postgrad Med J, 51 (8), suppl 88-92
PubMed 215987 -
Neonatal screening for hyperlipidaemia
Postgrad Med J, 51 (8), 88-92
PubMed 1221382
Publications 1974
-
[Finnish descendants in the municipality of Sor-Varanger--II. An investigation of blood pressure, height, weight, cholesterol, triglycerides and lipoproteins among Finnish descendant men--and the effect of a diet change]
Tidsskr Nor Laegeforen, 94 (26), 1565-72
PubMed 4422489 -
[Routine methods for fibrinogen determination]
Tidsskr Nor Laegeforen, 94 (30), 2085-7
PubMed 4214421 -
[The D-xylose-tolerance test as screeningtest for malabsorption diseases in children]
Tidsskr Nor Laegeforen, 94 (18), 1192-5
PubMed 4839995
Publications 1973
-
[D-xylose tolerance in malabsorption. Method of determination of D-xylose in serum and urine]
Tidsskr Nor Laegeforen, 93 (28), 2103-5
PubMed 4773981